Home | News | Directories | Calendar | Maps | Contact Us | Webmail
Perelman School of Medicine at the University of Pennsylvania Advanced Search

Roger B Cohen,

Roger B Cohen

faculty photo
Professor of Medicine at the Hospital of the University of Pennsylvania
Department: Medicine

Contact information
Division of Hematology-Oncology
Perelman Center for Advanced Medicine
10th Floor, South Pavilion
Office #10-205
Philadelphia, PA 19104
Office: 215-662-4469
Fax: 215-349-5326
A.B. (Biochemical Sciences)
Harvard College (magna cum laude), 1976.
M.D. (Medicine)
Harvard Medical School, 1980.
Permanent link
Perelman School of Medicine > Faculty > Search

Selected Publications

Bauml Joshua M, Troxel Andrea, Epperson C Neill, Cohen Roger B, Schmitz Kathryn, Stricker Carrie, Shulman Lawrence N, Bradbury Angela, Mao Jun J, Langer Corey J: Scan-associated distress in lung cancer: Quantifying the impact of "scanxiety". Lung cancer (Amsterdam, Netherlands) 100: 110-3, Oct 2016.

Keefe S M, Hoffman-Censits J, Cohen R B, Mamtani R, Heitjan D, Eliasof S, Nixon A, Turnbull B, Garmey E G, Gunnarsson O, Waliki M, Ciconte J, Jayaraman L, Senderowicz A, Tellez A B, Hennessy M, Piscitelli A, Vaughn D, Smith A, Haas N B: Efficacy of the nanoparticle-drug conjugate CRLX101 in combination with bevacizumab in metastatic renal cell carcinoma: results of an investigator-initiated phase I-IIa clinical trial. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 27(8): 1579-85, Aug 2016.

Weiss Jared M, Bagley Stephen, Hwang Wei-Ting, Bauml Joshua, Olson Juneko Grilley, Cohen Roger B, Hayes David Neil, Langer Corey: Capecitabine and lapatinib for the first-line treatment of metastatic/recurrent head and neck squamous cell carcinoma. Cancer 122(15): 2350-5, May 2016.

Bauml Joshua, Haas Andrew, Simone Charles B, Li Susan Q, Cohen Roger B, Langer Corey J, Mao Jun J: Acupuncture for Dyspnea in Lung Cancer: Results of a Feasibility Trial. Integrative cancer therapies 15(3): 326-32, Apr 2016.

Maquilan Genevieve, Grover Surbhi, Xanthopoulos Eric, Evans Tracey L, Aggarwal Charu, Langer Corey J, Cohen Roger B, Stevenson James P, Simone Charles B, Rengan Ramesh: Analysis of the Relationship Between Response to Chemotherapy and Response to Radiation Therapy in Patients With Non-Small Cell Lung Cancer Receiving Sequential Treatment. American journal of clinical oncology Apr 2016.

Sedrak Mina S, Cohen Roger B, Merchant Raina M, Schapira Marilyn M: Cancer Communication in the Social Media Age. JAMA oncology 2(6): 822-3, Mar 2016.

Ahn Peter H, Mitra Nandita, Alonso-Basanta Michelle, Adappa Nithin D, Palmer James N, O'Malley Bert W, Rassekh Christopher H, Chalian Ara, Cohen Roger B, Lin Alexander: Nodal metastasis and elective nodal level treatment in sinonasal small-cell and sinonasal undifferentiated carcinoma: a surveillance, epidemiology and end results analysis. The British journal of radiology 89(1058): 20150488, Feb 2016.

Sarantopoulos John, Shapiro Geoffrey I, Cohen Roger B, Clark Jeffrey W, Kauh John S, Weiss Glen J, Cleary James M, Mahalingam Devalingam, Pickard Michael D, Faessel Hélène M, Berger Allison J, Burke Kristine, Mulligan George, Dezube Bruce J, Harvey R Donald: Phase I Study of the Investigational NEDD8-Activating Enzyme Inhibitor Pevonedistat (TAK-924/MLN4924) in Patients with Advanced Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 22(4): 847-57, Feb 2016.

Chiorean EG, Hurwitz HI, Cohen RB, Schwartz JD, Dalal RP, Fox FE, Gao L, Sweeney CJ.: Phase I study of every 2- or 3-week dosing of ramucirumab, a human immunoglobulin G1 monoclonal antibody targeting the vascular endothelial growth factor receptor-2 in patients with advanced solid tumors. Ann Oncol 26(6): 1230-7, March 2015

Goff Laura W, Cohen Roger B, Berlin Jordan D, de Braud Filippo G, Lyshchik Andrej, Noberasco Cristina, Bertolini Francesco, Carpentieri Marina, Stampino Corrado Gallo, Abbattista Antonello, Wang Erjan, Borghaei Hossein: A Phase I Study of the Anti-Activin Receptor-Like Kinase 1 (ALK-1) Monoclonal Antibody PF-03446962 in Patients with Advanced Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 22(9): 2146-54, Dec 2015.

back to top
Last updated: 09/07/2016
The Trustees of the University of Pennsylvania